Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 31, 2004Anti-Cancer Drugs

17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAngelika M. BurgerCancer ClinicHFHeinz‐Herbert FiebigZF Friedrichshafen (Germany)SSSherman F. StinsonReata Pharmaceuticals (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Burger et al. (2004) studied this question.

synapsesocial.com/papers/6a7031dcf44fa9f079ddc2a7https://doi.org/10.1097/00001813-200404000-00011
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Primary Bioassay of Human Tumor Stem Cells1977 · 1,653 citations
  2. 2erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships1995 · 140 citations
  3. 3Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.1994 · 1,451 citations
  4. 4Functional requirement of p23 and Hsp90 in telomerase complexes1999 · 543 citations
  5. 5Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenograftsin vivo2001 · 68 citations